Target intelligence / Profile preview

Adenoviral capsid surface

Molecular classification
Viral structural protein, Protein complex, Other
01

Overview

The adenoviral capsid surface is a complex, non-enveloped icosahedral structure primarily composed of three major proteins: hexon, penton base, and fiber [1]. It serves as the critical interface between the virus and the host, mediating initial attachment to cellular receptors such as the Coxsackievirus and Adenovirus Receptor (CAR) and facilitating subsequent internalization and endosomal escape [2]. In clinical contexts, the capsid is the primary target for the host's neutralizing antibody response, which can limit the effectiveness of adenoviral vectors used in gene therapy and vaccines [3]. Therapeutic approaches targeting the capsid include the administration of intravenous immunoglobulins for passive immunity and the development of engineered "stealth" capsids that evade immune detection [4]. Additionally, the capsid's structural proteins are targets for experimental small molecules and monoclonal antibodies designed to inhibit viral uncoating or block cell entry [5]. Understanding the molecular architecture of the capsid surface is essential for both treating natural infections and optimizing adenovirus-based delivery systems [6].

Other names
Adenovirus capsidAdenoviral coatAdenoviral shellAdenovirus icosahedral capsid
02

Mechanism of action

Neutralization of viral infectivity by blocking receptor binding sites or preventing the conformational changes required for endosomal escape and uncoating.

03

Biological functions

Viral attachmentHost cell entryEndosomal escapeViral genome protectionIntracellular traffickingImmune responseOther
04

Disease associations

InfectionOther
05

Safety considerations

Pre-existing systemic immunityInnate immune activation (cytokine storm)HepatotoxicitySequestration by Kupffer cellsThrombocytopenia
06

Interacting drugs

Intravenous immunoglobulin

3 more in the full profile.

07

Biomarkers

Anti-adenovirus IgG titerAnti-adenovirus IgM titerAdenovirus DNA viral loadHexon protein antigen levels

Beyond the preview

Go deeper on Adenoviral capsid surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenoviral capsid surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call